Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women

Inclusion Criteria: * Subject is 18 to 45 years of age * Subject is willing to provide informed consent * Subject enrolling at a study OB-GYN or MFM site is in the opinion of the physician able to provide 20 mL of whole blood and will comply with all study procedures * Subject has a singleton fetus of 28 0/7 to 36 6/7 weeks' gestational age using 2014 ACOG Dating Criteria (pregnancies starting as twins but complicated with either vanishing twin syndrome or fetal demise of one twin before 14 weeks, are eligible for inclusion) * Patient presenting with clinical suspicion of Pre-E based on one or more of the following clinical signs and symptoms of Pre-E: * New onset increased blood pressure in otherwise normotensive patient * Worsening hypertension in a patient with pre-existing hypertension * New onset proteinuria or worsening of pre-existing proteinuria * Any other clinical finding typically associated with suspicion of Pre-E and requiring workup to rule-out Pre-E Exclusion Criteria: * Pregnancy is non-viable, as evidenced by absence of fetal cardiac activity * Major fetal anomaly or chromosomal aneuploidy * Current dialysis for kidney failure, including continuous ambulatory peritoneal dialysis